The National Evaluation System for Health Technology Coordinating Center (NESTcc) this week announced the first round of test cases that address “topics of high-priority” involving the medical device industry using both real-world data (RWD) and real-world evidence (RWE).
According to a press release, the test-cases look to accomplish two objectives:
- Analyze the feasibility for medical device companies to utilize RWD sources and NESTcc’s first Network Collaborators set; and
- Use the test cases to better identify areas where NESTcc could potentially cut costs.
“It’s exciting to reveal this milestone for NEST with the launch of these first test-cases that will explore the feasibility of generating Real-World Evidence with health systems and coordinated registry networks through the NESTcc Network Collaborators,” NESTcc Executive Director Rachael Fleurence said in a statement. “These test-cases will show proof-of-concept for the use of Real-World Evidence for medical devices in preparation for regulatory submissions, such as label expansions, and to meet post-market surveillance requirements.”